Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Global Undifferentiated Pleomorphic Sarcoma Therapeutics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Soft tissue cancers include malignant fibrous histiocytoma, often undifferentiated pleomorphic sarcoma. It's rare cancer that frequently metastasizes to other body regions and returns after ... Read More
-
Global Cutaneous Squamous Cell Carcinoma Market - 2022-2029
... a CAGR of 7.2 % during the forecast period (2022-2029). Cancer starts in the cells that make up the epidermis (the outer layer of the skin). It commonly develops in parts of the skin that ... Read More
-
Global Artificial Intelligence (AI) in Oncology Market Size study, by Treatment (Hemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy, And Others) by Type (Lung Cancer, Breast Cancer, Melanoma Cancer, Prostate Cancer, Colorectal Cancer, Among Others), by Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028
... Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028 Global Artificial Intelligence (AI) in Oncology Market is valued at approximately USD XX Million in 2021 and is anticipated to grow with a healthy ... Read More
-
Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... is expected to grow from US$ 3,864.66 million in 2022 to US$ 5,169.04 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028. The growing pharmaceutical industry in ... Read More
-
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Peripheral T-Cell Lymphomas (PTCL) Clinical trials scenario. This report provides top line data ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer ... Read More
-
Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The APAC human ... Read More
-
Europe Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The Europe human papillomavirus ... Read More
-
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
South America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others) The South America ... Read More
-
Middle East & Africa Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The ... Read More
-
North America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others) The North America ... Read More
-
North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... America is expected to grow from US$ 8,559.27 million in 2022 to US$ 11,198.11 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028. Colorectal cancer is one ... Read More
-
Digital Marketing Trends in Hepatocellular Carcinoma
... by Bristol Myers Squibb's (BMS’s) Opdivo.com (1.2 million visits) and Genentech's Tecentriq.com (497,000 visits). The highest proportion of traffic to these sites originated from direct sources, followed by organic and referral traffic. Between August 2021 ... Read More
-
Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... expected to grow from US$ 4,627.82 million in 2022 to US$ 5,819.96 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2022 to 2028. The market for colorectal cancer is ... Read More
-
Cytokine Market, By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, and Other Cytokine Types), By Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cytokines are a category of small proteins important in cell signaling. They are small proteins that ... Read More
-
Mammography Biopsy Chair Market, by Product Type (Electric, Manual), by Feature (Reclining, Non-Reclining), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others (Cancer Research Institutes, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Mammography is specialized medical imaging technique in which a low-dose x-ray system utilized to view within the ... Read More
-
Slide Stainer Market by Product (Reagent (Stains, Probes, ABS), Equipment (Automated, Manual)), Technology (H&E, IHC, ISH, Cytology), Application (Disease Diagnosis (Cancer) Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2027
... stainer market is valued at USD 4.3 billion in 2022 and is projected to reach USD 5.9 billion in 2027 at a CAGR of 6.8% from 2022 to 2027. The major factors driving the growth ... Read More
-
Cancer Biomarkers Market (Type: Protein, Genetics, and Others; and Type of Cancer: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Ovarian, Liver, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Market – Scope of Report TMR’s report on the global cancer biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the ... Read More
-
Small Animal Imaging Market, by Product Type (Optical Imaging Systems {Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, and X-Ray/Optical Imaging Systems}, Nuclear Imaging Systems {Micro-PET (Positron Emission Tomography) Systems, Micro-SPECT (Single-Photon Emission Computed Tomography) Systems, and Trimodality (SPECT/PET/CT) Systems}, MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, and Others {Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others}), by Application (Monitoring Drug Treatment Response, Bio-distribution Studies, Cancer Cell Detection, Biomarkers, and Others {Longitudinal Studies and Epigenetics, among others}), by End User (Biotechnology and Pharmaceutical Companies, Academic/ Research Institutes, and Others {Contract Research Organizations, Laboratories, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
... and Trimodality (SPECT/PET/CT) Systems}, MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, and Others {Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others}), by Application (Monitoring Drug Treatment Response, Bio-distribution ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than one million incidence cases of HER2- BC across 16 pharmaceutical markets. There are several marketed innovator drugs for the treatment of HER2- BC, mostly kinase inhibitors. A total of seven ... Read More
-
Global Cancer Biomarkers Market Opportunity Analysis and Industry Forecast till 2031: By Biomarker Type (Protein Biomarker, Genetic Biomarker, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Profiling Technologies (Omics Technology, Imaging Technologies, Immunoassays, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessments, Others); and By Region
... (Omics Technology, Imaging Technologies, Immunoassays, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessments, Others); and By Region The global cancer biomarkers market size was USD 13.4 billion in 2021 and it is ... Read More
-
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense mechanism and control the disease progression. The first PD-1 ... Read More
-
Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 - 2030
... size is expected to reach USD 3.99 billion by 2030, according to a new study by Polaris Market Research. The report “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, ... Read More
Research Assistance
